Biomanufacturers Demand Higher Quality Standards in 2016

Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.

Quality considerations have always been vital to biotherapeutic developers and CMOs. Yet, in 2016, it seems that these considerations are taking on a new emphasis. One of the main industry trends seen this year-increased attention to continuous bioprocessing-is at least partly driven by the potential for improved product quality.

Download the

BioPharm International 2016 Outsourcing Resources eBook

.

Articles in this issue

over 9 years ago

Article

Contract Service Providers Gear Up to Develop Emerging Therapies

over 9 years ago

Article

Biopharma Service Providers Address a Full Plate of Challenges

over 9 years ago

Article

Dealing with Pharmaceutical Supply-Chain Complexities

over 9 years ago

Article

Keeping it Simple: Collaborating for Success in Drug Delivery

over 9 years ago

Article

Regulatory Reform in China: Implications for Global Biopharmaceutical Companies

over 9 years ago

Article

Preventing Phase III Failures

over 9 years ago

Article

Outsourcing Industry Marked by Considerable Investments in 2016

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!